devinitorg/iati-policy-markers huggingface dataset:
NIHR HPSR-DA: Equitable access to quality trauma systems in Lower and Middle Income Countries. Assessing gaps and developing priorities Deaths from trauma, especially due to road traffic collisions, are prevalent in lower and middle income countries (LMICs); trauma causes a substantial burden of disability in survivors. Equitable access to quality health care is essential to treat trauma patients. Expanding on our preliminary work in Rwanda, this project will: - Convene workshops with providers and policy makers to delineate barriers, knowledge, and priorities in access to care in three contrasting countries - Map access to trauma care as a complex health system problem - Collect data from patients on their experiences of barriers to and quality of care - Build research capacity in partner countries to enable further work - Develop a network of trauma researchers - Convene a meeting of investigators, patient representatives, and policy makers to discuss findings and, in combination with ongoing studies and literature review results, identify and agree upon priorities for a programme for future research 1) Develop an evidence-based approach, drawing on existing global evidence to decision making (EtD) frameworks, to guide the adaptation of the WHO EDL to national health system needs and establish a Research Initiative for Evidence-based diagnostics in Africa. 2) Engage with decision makers in health policy and practice in East Africa to jointly decide on information needs and the development of methods, skills and capacity required. 
3) Conduct a systematic stakeholder analysis to identify local, national, regional and international stakeholders responsible for the EDL in Kenya and Uganda. 
4) Conduct a needs analysis thorough literature review and engagement with the identified stakeholders to identify the desired and current status of the EDL lists, decision-making and health system barriers to their adaption and implementation, desired local decision-making approaches and finally refine our proposed research question and study methods.
NIHR Global Health Research Group on Evidence to Policy Pathway to Immunisation in China (NIHR EPIC) A UK and low- and middle-income country (LMIC) partnership that aims to conduct applied vaccine research to help decision makers build a vaccination programme that ensures reliable, affordable, equitable and uninterrupted supply of vaccines to the poorest and most at-risk members of the population. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. NIHR Global Health Research Group on Evidence to Policy Pathway to Immunisation in China (NIHR EPIC) objectives: 1) Conduct research to inform vaccination policy in China, focused around three themes: (i) understanding the epidemiology and burden of vaccine-preventable diseases, (ii) understanding manufacturing capacity, public demand and confidence around vaccines, and (iii) modelling the health, economic and equity impact of vaccine strategies, particularly on vulnerable populations. 2) Use results in collaboration with key stakeholders to strengthen the evidence-to-policy pathway for immunisation in China (and eventually other countries). 3) Set up a cross-national and cross-sectoral collaboration between four British and Chinese public health and academic organisations: the London School of Hygiene and Tropical Medicine (LSHTM), Public Health England (PHE), Chinese Centre for Disease Control and Prevention (China CDC) and Fudan University (Fudan).
NIHR Global Health Research Group on African Snakebite Research A UK and low- and middle-income country (LMIC) partnership that aims to establish self-sustaining regional hubs of snakebite expertise to support national and regional authorities design and implement systems to reduce snakebite deaths and disability. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) Snakebite Rapid Diagnostic Test: with our Kenya partners and the Liverpool School of Tropical Medicine (LSTM)’s Research Centre for Drugs and Diagnosis, we will develop Africa’s first near-patient snakebite diagnostic kit. 2) Generation of Important New Research Data by: a) Conducting clinical pharmacological studies of systemic venom/anti-venom interactions. b) Conducting hospital and community surveys in each country to develop accurate estimates of snakebite burden and socio-economic impact. c) Utilising LSTM’s preclinical antivenom testing expertise to develop systems for rapid and costeffective antivenom efficacy testing, initially in Kenya. 3) Capacity-Strengthening Benefits: a) We will pilot and establish region-specific first aid, hospital and rehabilitation guidelines and clinical training. b) We will test, first in Kenya and then in Nigeria and Cameroon, the first Snakebite Emergency Response System - a smartphone app-activation of motorcycle ambulances to speed rural snakebite victims to hospital. This will inexpensively improve local health capacity and snakebite outcomes.
NIHR Global Health Research Group on Global Surgical Technologies A UK and low- and middle-income country (LMIC) partnership that aims to identify areas of surgical need and develop and evaluate new context-appropriate technological solutions. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) Building on established academic and surgical networks and working with local ministries of health, NGOs, and private healthcare providers to conduct collaborative research. 2) Undertaking social science research to better understand local healthcare systems, including cultural and social attitudes to surgery, defining the unmet surgical needs, and assessing existing research strengths and capacity. 3) Using NIHR medical technology capability (Leeds NIHR Healthcare Technology Co-operative and Leeds Diagnostic Evaluation Centre) to develop disruptive, yet affordable, solutions to unmet surgical needs relevant to local healthcare settings. 4) Undertaking clinical evaluations, including cost-effectiveness assessment, in partnership with local researchers to inform wider adoption. 5) Establishing an advocacy programme, linked to other global health organisations, to influence awareness of health inequalities and promote the impact of our research.
European and Developing Countries Clinical Trials Partnership (EDCTP) phase II: funding for 2018 work plan The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. NIHR has supported research as part of the 2018 Workplan focussed on: ‘Advances in product development for effective prevention, treatment and management of co-infections and co-morbidities’; ‘Diagnostic tools for poverty-related diseases Challenge’; and "Vaccines for diarrhoeal diseases or lower respiratory tract infections". This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase II programme (GB-GOV-10-EDCTP2). 1) Support actions that lead to improvements in  the prevention, treatment and/or clinical management of co-infections and co-morbidities in sub-Saharan Africa; 2) provide funding to projects focusing on validation of clinical performance and/or implementation of new or improved diagnostic tools and technologies for the detection of any of the PRDs including co-infections 3) improve the performance of diagnosis, prediction, monitoring, intervention or assessment of therapeutic response, with a significant impact on clinical decision and health outcomes 4) contribute towards the reduction of the burden of diarrhoeal diseases or lower respiratory tract infections in sub-Saharan Africa and lead to the advancement of vaccine candidates along the product development pipeline.
European and Developing Countries Clinical Trials Partnership (EDCTP) phase II The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The NIHR provided funding to the European and Developing Countries Clinical Trials Partnership (EDCTP) which aims to support collaborative research that accelerates the clinical development of new or improved interventions to prevent or treat poverty related diseases as well as emerging and re-emerging infectious diseases affecting sub-Saharan Africa. The NIHR has supported research calls as part of the 2016, 2017 and 2018 workplans, in addition to programme management activities associated with enhancing the wider programme. 1) Increase the number of new or improved medical interventions for poverty-related diseases (PRDs), including neglected ones; 2) Strengthen cooperation with sub-Saharan African countries, in particular on building their capacity for conducting clinical trials in compliance with fundamental ethical principles and relevant national, EU and international legislation; 3) Better coordinate, align and, where appropriate, integrate relevant national programmes to increase the cost-effectiveness of European public investments; 4) Extend international cooperation with other public and private partners to ensure that the impact of all research is maximised and that synergies can be taken into consideration and to achieve leveraging of resources and investments; 5) Increase impact due to effective cooperation with relevant EU initiatives, including its development assistance.
Strengthening health systems by addressing community health workers’ mental wellbeing and agency Although community health workers (CHWs) play a crucial human resource role in health systems of many low and middle-income countries, they are largely invisible, under supported and not adequately recognised. Lack of support generates many stressors for CHWs which are further exacerbated when delivering services in challenging contexts (e.g COVID-19, informal settlements, remote areas). Chronic job-related stressors can have a lasting impact on CHW wellbeing which ultimately affects their performance and capacity to effectively undertake their important role as frontline health workers. Drawing on wellbeing and resilience frameworks while considering the hardware (e.g. training) and software (e.g. community cohesion and support) components of the health system, we aim to identify the stressors, challenges, constraints and opportunities faced by CHWs and communities. We will utilise this evidence to co-develop, pilot and evaluate a holistic health systems support package for CHWs in two different LMIC contexts to support CHW wellbeing and agency, ultimately contributing to enhanced health systems resilience. We will focus specifically on integrating support for the mental wellbeing of CHWs, a previously neglected area. . Objectives:
1. To identify strategies and programmes to enhance CHWs’ wellbeing, with a specific focus on mental health that is equitable, sustainable and acceptable in LMIC settings.
2. To co-design and test innovative health system interventions that are responsive to the diverse personal and job-related stressors (social, material and human) experienced by CHWs.
3. To enhance the quality and equity of existing support approaches to ensure a focus on mental wellbeing that prioritises the diverse needs of CHWs.
4. To contribute evidence and knowledge to inform and advocate for support of CHWs mental wellbeing in future research and programme design in other health systems
Methods: Our research will apply ‘Community Based Participatory Research’ (CBPR) situating CHWs and stakeholders as equitable partners and co-researchers who are central to data collection, analyses and co-designing solutions. We will:
1) Undertake analysis of existing global and national policies and practices that support CHWs wellbeing.
2) Conduct interdisciplinary research with CHWs, supervisors and key decision/policy makers using qualitative, participatory methods (photo-voice, stepping stones, body mapping), quantitative surveys, and embedded participatory evaluation to generate evidence on their experiences and challenges.
3) Utilize evidence to co-produce interventions with CHWs and key stakeholders, to support CHWs’ mental wellbeing, promoting their resilience and agency to strengthen health system resilience.
4) Pilot and evaluate interventions for cost, equity, feasibility, acceptability and scale-up.
Team: Our interdisciplinary team comprises researchers, implementers, policy makers, with direct engagements and collaborations with CHWs, government, non-governmental organisations, or in each country.
NIHR Global Health Research Group on Improving the Management of Acute Brain Infections A UK and low- and middle-income country (LMIC) partnership that aims to improve the diagnosis of acute brain infections in adults and children, guide treatment and improve outcomes, while developing research capacity and establishing a broad network of hospitals interested in studying brain infections. 1) Understand the behaviours, knowledge, attitudes and practice of patients, families and health care workers to suspected brain infection through interviews and focus group discussions. 2) Improve early management through development of a compound intervention by working with service users and providers to develop an intervention which improves patient management, and addresses underuse of lumber puncture, and inadequate laboratory methods. 3) Strengthen diagnosis through pathogen discovery and host genomic approaches. 4) Consider the funding impacts of any changes in care in advance of their development, to help determine if they are worth exploring, and the cost at which they might be implemented. 5) Provide training, capacity building and long-term sustainability to include studentships on the Masters in Research, PhD exchange projects, short course staff training, and online research training modules, both generic and specific to brain infections, offered through partnership with the Global Health Research Network.
NIHR RIGHT3: Intervention to screen and treat multimorbidity in high-risk patients. A UK and low-and-middle-income-country (LMIC) research partnership that aims to design and test a system which identifies patients suffering from multiple diseases (multimorbidity) when they seek emergency care in hospitals in Malawi and Tanzania. This could improve early disease treatment (reducing death), and ensure better follow-up (preventing complications, disability, and hospital readmission). The research project is being implemented by Malawi Liverpool Wellcome Trust (Malawi), Kilimanjaro Christian Medical Centre (Tanzania) and Muhimbili University (Tanzania), in collaboration with Liverpool School of Tropical Medicine (UK), between 01-09-2021 and 31-12-2025. 1. To confirm the prevalence of multimorbidity in patients attending acute hospital services in Malawi and Tanzania.
2. To create a strategy to recognise and treat multimorbidity using point-of-care tests incorporated into the emergency care pathways in Malawi and Tanzania, maximising acceptability to patients and healthcare workers, and optimising the impact of available resources.
3. To test the optimised emergency care pathway intervention with a primary outcome of hospital admission-free survival three months after hospital admission
Research for Health in Humanitarian Crises (R2HC) phase 3 The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The aim of the Research for Health in Humanitarian Crises (R2HC) programme is to develop more effective responses to humanitarian challenges by providing significant funding for high-quality research on the effectiveness of health interventions in humanitarian crises. 1) To strengthen the evidence base around the health challenges associated with humanitarian crises, leading to demonstrated improvements in the effectiveness/efficiency of humanitarian health interventions and programming. 2) Fund research grants that investigate recognised disaster/humanitarian health challenges with collaborative research teams. 3) Produce peer-reviewed publications and products that contribute to informing the evidence base and improving public health humanitarian response. 4) Advance the global public health knowledge-base through practical operational guidance and by improving practice on ethical and methodological approaches to conducting health research programmes in operational humanitarian contexts. 5) Expand and enhance collaborative partnerships between biomedical/public health researchers and the humanitarian sector.
NIHR RIGHT1: Transforming the Treatment and Prevention of Leprosy and Buruli ulcers in Low and Middle-Income Countries (LMICs) A UK and low- and middle-income country (LMIC) research partnership that aims to improve care and reduce stigma and social isolation for leprosy and Buruli ulcer in Nepal, India and Nigeria. 1. To improve self-care in the community for patients who are at risk of recurring leprosy ulcers. 
2. To better understand the needs of patients with Buruli ulcer and the barriers to meeting those needs. 
3. To develop new and improved methods of clinical care for both leprosy and Buruli ulcer patients.
Grand Challenges Canada - Global Mental Health Programme The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). This Programme is administered by Grand Challenges Canada (GCC) and funded in partnership with the National Institute for Health and Care Research (NIHR). Through the programme, the NIHR has funded a portfolio of innovative projects in ODA-eligible countries to develop new approaches which meet the mental health needs of the most vulnerable young people aged 10-24 years. The programme aims to seed and transition to scale funding for high impact innovations that improve treatments and/or expand access to care for people living with or are at risk of mental disorders. 75% of all mental disorders start before the age of 24 – the seed call will focus on the mental health needs of young people in low-and middle-income countries.
National Institute for Health and Care Research (NIHR)’s third Global Research Professorship call National Institute for Health and Care Research (NIHR)’s third Global Research Professorship call. The Global Research Professorships programme funds research leaders, with a track-record of applied health research in low- and middle-income countries (LMICs), to promote effective translation of research and to strengthen research leadership at the highest academic levels. Funding of up to £2m over up to 5 years is awarded to Professors working in close partnership with a research institution in an LMIC. By the end of the award, NIHR Global Research Professors will be expected to: 

1) Have demonstrated research leadership at a national and/or international level.
2) Have been developed and protected by their institutions, including being relieved of administrative tasks.
3) Enhance existing and establish new research collaborations in low- and middle-income countries (LMICs).
4) Have supported training and capacity strengthening/mentorship within LMIC and UK (if applicable) institutions that enhances research capacity for future global health and care research.
NIHR Global Health Research Group on Neurotrauma A UK and low- and middle-income country (LMIC) partnership that aims to advance global neurotrauma care and research in order to save lives, reduce disability and improve the quality of life for patients with traumatic brain injury. This research has the direct and primary aim of improving the health, wellbeing and economic development of people in LMICs. 1) Map the current landscape, understand the current systems and challenges in traumatic brain injury (TBI) clinical care and research in a range of LMIC (Colombia, Ethiopia, India, Indonesia, Malaysia, Myanmar, South Africa,Tanzania). 2) develop organisational and cost-effective solutions to the challenges faced in these areas. 3) establish clinical networks, research capacity, and pathways for the testing and implementation of the proposed solutions in the partner LMIC.
European and Developing Countries Clinical Trials Partnership (EDCTP) phase III: funding for admin and programme management activities The UK Department of Health and Social Care (DHSC) funds outstanding global health research through the National Institute for Health and Care Research (NIHR). The Global Health European and Developing Countries Clinical Trials Partnership 3 (Global Health EDCTP3) Joint Undertaking works to deliver new solutions to reduce the burden of poverty-related infectious diseases in sub-Saharan Africa and to strengthen research capacities to prepare and respond to re-emerging infectious diseases. EDCTP Members who have committed to participating in Global Health EDCTP3 are required to make an annual contribution to the EDCTP Association administrative costs. NIHR as a member provides a funding contribution to the EDCTP Association annual administrative costs and EDCTP 3 programme management activities. This activity is a component of European and Developing Countries Clinical Trials Partnership (EDCTP) phase III (Global Health EDCTP3) programme (A7397_AA7398). Support the European & Developing Countries Clinical Trials Partnership to effectively deliver EDCTP programmes to benefit people in sub-Saharan Africa.
Royal Society of Tropical Medicine and Hygiene Early Career Grants Scheme National Institute for Health and Care Research (NIHR)’s funding to the Royal Society of Tropical Medicine and Hygiene (RSTMH) Early Career Grants Scheme supports early career researchers in low and middle income countries (LMICs) to develop their research skills and expertise. This partnership contributes to the NIHR Global Health Research priority to strengthen research capacity in LMICs. 1) Enable early career researchers and global health professionals of LMIC nationality to undertake applied health research or fieldwork that directly and primarily benefits people in LMICs 
2) Develop and improve the research and management skills of early career LMIC researchers through leading a small independent research project 
3) Help early career LMIC researchers to widen their networks within their institutions, countries and potentially globally, and within their field of work
4) Establish a peer cohort of awardees to increase collaboration and networking opportunities 
5) Support early career LMIC researchers to progress their careers